USANA Health Sciences (USNA) Tops Q2 EPS by 32c

USANA Health Sciences (NYSE: USNA) reported Q2 EPS of $1.92, $0.32 better than the analyst estimate of $1.60. Revenue for the quarter came in at $233.2 million versus the consensus estimate of $212.94 million.

For earnings history and earnings-related data on USANA Health Sciences (USNA) click here.

You May Also Be Interested In

• Broadcom credit risk measures rise amid AI financing deals
• Blackstone Mortgage Trust (BXMT) Reiterated at Market Perform by Citizens
• Merck (MRK) PT Raised to $180 at Wolfe Research